TO THE EDITOR Known steroidogenic functions of the skin that are represented by the synthesis and metabolism of androgens and estrogens (Chen et al., 2002; Zouboulis and Degitz, 2004) probably include corticosteroids (Slominski et al., 2000; Slominski, 2005) . Thus, the skin expresses both the genes and proteins involved in the synthesis of adrenal corticosteroids (Slominski et al., 1996 (Slominski et al., , 1999 (Slominski et al., , 2004 Rogoff et al., 2001) . Metabolism of progesterone to deoxycorticosterone and corticosterone has been documented in melanoma cells and in rat skin (Slominski et al., 1999 (Slominski et al., , 2000 ; corticotropin-releasing hormone-and ACTHregulated cortisol production was demonstrated in histocultured human hair follicles (Ito et al., 2005) ; and corticotropin-releasing hormone and ACTH enhancement of cortisol production was demonstrated in epidermal melanocytes (Slominski et al., 2005b) . In contrast, in human dermal fibroblasts cortisol production was not enhanced by corticotropin-releasing hormone and ACTH (there was only selective stimulation of corticosterone production; Slominski et al., 2005a) . However, since the cortisol-like immunoreactivity was detected by ELISA, we investigated the chemical nature of the antigen.
Normal human adult dermal fibroblasts (from lightly pigmented female: lot 1C0317 (Cascade Biologics Inc., Portland, OR)) were cultured in Epilife medium with EpiLife Defined Growth Supplement free of serum (Cascade Biologics). The cells were washed twice with phosphate-buffered saline before incubation in supplement-free EpiLife medium with progesterone (10 À6 M), ACTH (10 À6 M, but added again after 12 h), and/or IBMX (phosphodiesterase inhibitor) (10 À4 M). After 24 hours, media were extracted for cortisol identification and quantification as described previously (Slominski et al., 2005b) . Cortisol in supernatants was measured with ELISA (Bio-Quant Inc., San Diego, CA), whereas chemical nature of the compounds was assessed by liquid chromatography mass spectrometry analysis with auto-mass spectrometry/mass spectrometry as described previously (Slominski et al., 2005b) . Data were analyzed using Prism 4.00 (GraphPad Software), and is presented as mean þ SEM (n ¼ 4).
Testing dermal fibroblasts for the release of cortisol into the media showed that addition of progesterone (10 À6 M) stimulated significantly (4.3-fold) cortisol production; further enhancement (2.5 times) was observed after the addition of 10 À4 M IBMX (phosphodiestearse inhibitor) but not ACTH (11-fold increase over the basal values obtained from unstimulated cells; Figure 1 ). The addition of corticotropin-releasing hormone did not affect the production of cortisol (not shown).
Liquid chromatography mass spectrometry analyses of extracted steroids showed the presence of an [M þ H] þ ion at m/z 363 (real mass 362) with retention time of 11 minutes identical to the cortisol standard (Figure 2 ). Final confirmation of the product identity as cortisol was obtained with mass spectrometry/mass spectrometry analysis that yielded the same fragment ions as those of the cortisol standard: Figure 2 ). These data document the capability of human dermal fibroblasts to produce cortisol molecules identified by rigorous analysis with liquid chromatography mass spectrometry 2 . Moreover, and similar to normal (Slominski et al., 2005b) and malignant melanocytes (Slominski et al., 1999) , fibroblasts also displayed a precursor substrate relationship in the accumulation of cortisol, for example, the addition of progesteronestimulated production of the final corticosteroid cortisol, which was further enhanced by a phosphodiesterase inhibitor (IBMX). Nevertheless, in contrast to melanocytes ACTH and corticotropin-releasing hormone did not stimulate cortisol production in fibroblasts, related, perhaps, to defective coupling of MC-2R (if expressed) to intracellular signaling of the glucosteroidogenic pathway in cultured fibroblasts. Thus, these studies extend the ex vivo finding of cortisol production by hair follicles (Ito et al., 2005) , adding an important component of heterogeneity to the pleiotropic expression of hypothalamic-pituitary-adrenal mediators in the skin (Slominski and Wortsman, 2000; Slominski, 2005) . The role of these factors in the cutaneous response to stress remains to be fully characterized. 
